- Report
- March 2024
- 200 Pages
Global
From €4022EUR$4,150USD£3,445GBP
- Report
- January 2024
- 200 Pages
Global
From €4022EUR$4,150USD£3,445GBP
- Report
- January 2023
- 470 Pages
Global
From €4846EUR$5,000USD£4,150GBP
- Report
- April 2023
- 117 Pages
North America
From €4603EUR$4,750USD£3,943GBP
- Report
- April 2023
- 70 Pages
Canada
From €4603EUR$4,750USD£3,943GBP
- Report
- April 2023
- 85 Pages
Europe
From €4603EUR$4,750USD£3,943GBP
- Report
- April 2023
- 125 Pages
Global
From €4603EUR$4,750USD£3,943GBP
- Report
- August 2020
- 114 Pages
Global
From €4119EUR$4,250USD£3,528GBP
- Report
- February 2018
- 115 Pages
Global
From €4119EUR$4,250USD£3,528GBP
- Report
- February 2024
- 180 Pages
Global
From €3828EUR$3,950USD£3,279GBP
- Report
- April 2023
- 180 Pages
Global
From €3150EUR$3,250USD£2,698GBP
- Report
- January 2022
- 60 Pages
Global
From €3828EUR$3,950USD£3,279GBP
- Report
- January 2022
- 60 Pages
Global
From €3828EUR$3,950USD£3,279GBP
- Report
- January 2022
- 60 Pages
Global
From €3828EUR$3,950USD£3,279GBP
- Report
- May 2021
- 250 Pages
Global
From €8674EUR$8,950USD£7,429GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- August 2022
United States
From €1880EUR$1,940USD£1,610GBP
- Report
- August 2021
Global
From €3867EUR$3,990USD£3,312GBP
- Report
- August 2021
Europe
From €3314EUR$3,420USD£2,839GBP
- Report
- August 2022
- 115 Pages
Global
From €4361EUR$4,500USD£3,735GBP
The Glaucoma Drug market is a subset of the Optical Disorders Drugs market, which includes medications used to treat a variety of eye conditions. Glaucoma is a group of eye diseases that cause damage to the optic nerve, resulting in vision loss. Glaucoma drugs are used to reduce intraocular pressure, which is the main risk factor for glaucoma. These drugs can be administered orally, topically, or through injections. Commonly used glaucoma drugs include prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors, and cholinergic agonists.
Some of the major companies in the Glaucoma Drug market include Allergan, Pfizer, Merck, Novartis, Bausch Health, Sun Pharmaceuticals, Santen Pharmaceuticals, and Alcon. Show Less Read more